Aberrant mitochondrial bioenergetics in the cerebral cortex of the Fmr1 knockout mouse model of fragile X syndrome. 2020

Simona D'Antoni, and Lidia de Bari, and Daniela Valenti, and Marina Borro, and Carmela Maria Bonaccorso, and Maurizio Simmaco, and Rosa Anna Vacca, and Maria Vincenza Catania
Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), Via Paolo Gaifami 18, I-95126 Catania, Italy.

Impaired energy metabolism may play a role in the pathogenesis of neurodevelopmental disorders including fragile X syndrome (FXS). We checked brain energy status and some aspects of cell bioenergetics, namely the activity of key glycolytic enzymes, glycerol-3-phosphate shuttle and mitochondrial respiratory chain (MRC) complexes, in the cerebral cortex of the Fmr1 knockout (KO) mouse model of FXS. We found that, despite a hyperactivation of MRC complexes, adenosine triphosphate (ATP) production via mitochondrial oxidative phosphorylation (OXPHOS) is compromised, resulting in brain energy impairment in juvenile and late-adult Fmr1 KO mice. Thus, an altered mitochondrial energy metabolism may contribute to neurological impairment in FXS.

UI MeSH Term Description Entries
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005600 Fragile X Syndrome A condition characterized genotypically by mutation of the distal end of the long arm of the X chromosome (at gene loci FRAXA or FRAXE) and phenotypically by cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. INTELLECTUAL DISABILITY occurs in nearly all males and roughly 50% of females with the full mutation of FRAXA. (From Menkes, Textbook of Child Neurology, 5th ed, p226) FRAXA Syndrome,FRAXE Syndrome,Martin-Bell Syndrome,Fra(X) Syndrome,Fragile X Mental Retardation Syndrome,Fragile X-F Mental Retardation Syndrome,Mar (X) Syndrome,Marker X Syndrome,Mental Retardation, X-Linked, Associated With Fragile Site Fraxe,Mental Retardation, X-Linked, Associated With Marxq28,X-Linked Mental Retardation and Macroorchidism,FRAXA Syndromes,FRAXE Syndromes,Fragile X Syndromes,Marker X Syndromes,Martin Bell Syndrome,Syndrome, FRAXA,Syndrome, FRAXE,Syndrome, Fragile X,Syndrome, Marker X,Syndrome, Martin-Bell,Syndromes, FRAXA,Syndromes, FRAXE,Syndromes, Fragile X,Syndromes, Marker X,X Linked Mental Retardation and Macroorchidism
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051860 Fragile X Mental Retardation Protein A RNA-binding protein that is found predominately in the CYTOPLASM. It helps regulate GENETIC TRANSLATION in NEURONS and is absent or under-expressed in FRAGILE X SYNDROME. FMRP Protein,Fragile X Mental Retardation-1 Protein,Fragile X Mental Retardation 1 Protein
D018345 Mice, Knockout Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes. Knockout Mice,Mice, Knock-out,Mouse, Knockout,Knock-out Mice,Knockout Mouse,Mice, Knock out

Related Publications

Simona D'Antoni, and Lidia de Bari, and Daniela Valenti, and Marina Borro, and Carmela Maria Bonaccorso, and Maurizio Simmaco, and Rosa Anna Vacca, and Maria Vincenza Catania
November 2014, Intractable & rare diseases research,
Simona D'Antoni, and Lidia de Bari, and Daniela Valenti, and Marina Borro, and Carmela Maria Bonaccorso, and Maurizio Simmaco, and Rosa Anna Vacca, and Maria Vincenza Catania
June 2018, Scientific reports,
Simona D'Antoni, and Lidia de Bari, and Daniela Valenti, and Marina Borro, and Carmela Maria Bonaccorso, and Maurizio Simmaco, and Rosa Anna Vacca, and Maria Vincenza Catania
November 2021, Genome biology,
Simona D'Antoni, and Lidia de Bari, and Daniela Valenti, and Marina Borro, and Carmela Maria Bonaccorso, and Maurizio Simmaco, and Rosa Anna Vacca, and Maria Vincenza Catania
May 2016, Cerebral cortex (New York, N.Y. : 1991),
Simona D'Antoni, and Lidia de Bari, and Daniela Valenti, and Marina Borro, and Carmela Maria Bonaccorso, and Maurizio Simmaco, and Rosa Anna Vacca, and Maria Vincenza Catania
October 2005, Genes, brain, and behavior,
Simona D'Antoni, and Lidia de Bari, and Daniela Valenti, and Marina Borro, and Carmela Maria Bonaccorso, and Maurizio Simmaco, and Rosa Anna Vacca, and Maria Vincenza Catania
May 2002, Microscopy research and technique,
Simona D'Antoni, and Lidia de Bari, and Daniela Valenti, and Marina Borro, and Carmela Maria Bonaccorso, and Maurizio Simmaco, and Rosa Anna Vacca, and Maria Vincenza Catania
January 2015, Molecular autism,
Simona D'Antoni, and Lidia de Bari, and Daniela Valenti, and Marina Borro, and Carmela Maria Bonaccorso, and Maurizio Simmaco, and Rosa Anna Vacca, and Maria Vincenza Catania
January 2015, eNeuro,
Simona D'Antoni, and Lidia de Bari, and Daniela Valenti, and Marina Borro, and Carmela Maria Bonaccorso, and Maurizio Simmaco, and Rosa Anna Vacca, and Maria Vincenza Catania
December 2022, Scientific reports,
Simona D'Antoni, and Lidia de Bari, and Daniela Valenti, and Marina Borro, and Carmela Maria Bonaccorso, and Maurizio Simmaco, and Rosa Anna Vacca, and Maria Vincenza Catania
March 2017, Behavioural brain research,
Copied contents to your clipboard!